Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05VLV
|
|||
| Former ID |
DNC007795
|
|||
| Drug Name |
(10H-phenothiazin-10-yl)(m-tolyl)methanone
|
|||
| Synonyms |
CHEMBL239401; AC1MRTR9; (10H-phenothiazin-10-yl)(m-tolyl)methanone; Oprea1_358386; BDBM50219209; AKOS005197735; AKOS002684869
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H15NOS
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42
|
|||
| InChI |
1S/C20H15NOS/c1-14-7-6-8-15(13-14)20(22)21-16-9-2-4-11-18(16)23-19-12-5-3-10-17(19)21/h2-13H,1H3
|
|||
| InChIKey |
JSMJNESPMFVMAA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.